Systematic review and meta-analysis show benefits of continuous glucose monitoring for glycemic control in type 1 diabetes, suggesting improved clinical decision-making.
Background: Patients with type 1 diabetes mellitus (T1DM) require intensive glucose monitoring to achieve optimal glycemic control and prevent complications. While self-monitoring of blood glucose (SMBG) has long been the standard approach, continuous glucose monitoring (CGM) offers real-time data and trend analysis that may enhance clinical decision-making.
No takes yet. Share an insight, caveat, or question.
Poowaruttanawiwit et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: